BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
C4 Therapeutics
CCCC
$428M
| $141M | ﹤0.01% |
3,157,207
+524,783
| +20% | +$22.5M |
|
1977
Seer Inc
SEER
$119M
| $141M | ﹤0.01% |
4,079,920
+1,502,471
| +58% | +$51.7M |
|
1978
Albertsons Companies
ACI
$5.95B
| $141M | ﹤0.01% |
4,521,390
+545,970
| +14% | +$14.4M |
|
|
PENG
1979
Penguin Solutions Inc
PENG
$2.94B
| $141M | ﹤0.01% |
6,316,264
+1,920,448
| +44% | +$46M |
|
1980
Revolution Medicines
RVMD
$44.1B
| $140M | ﹤0.01% |
5,106,038
+287,908
| +6% | +$8.38M |
|
1981
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$587M
| $140M | ﹤0.01% |
3,888,665
-18,227
| -0.5% | -$670K |
|
|
VIVO
1982
DELISTED
Meridian Bioscience Inc
VIVO
| $140M | ﹤0.01% |
7,285,587
-127,024
| -2% | -$2.53M |
|
1983
Interface
TILE
$2.24B
| $140M | ﹤0.01% |
9,239,922
-308,508
| -3% | -$4.44M |
|
|
SILK
1984
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $140M | ﹤0.01% |
2,539,384
-1,045
| -0% | -$54.7K |
|
1985
ICF International
ICFI
$1.62B
| $140M | ﹤0.01% |
1,562,578
+15,622
| +1% | +$1.42M |
|
1986
Empire State Realty Trust
ESRT
$802M
| $139M | ﹤0.01% |
13,896,925
-382,864
| -3% | -$4.13M |
|
1987
Riot Platforms
RIOT
$7.65B
| $139M | ﹤0.01% |
5,411,953
-149,000
| -3% | -$4.8M |
|
1988
Petrobras Class A
PBR.A
$103B
| $139M | ﹤0.01% |
13,893,534
-1,857,213
| -12% | -$19.2M |
|
1989
QuinStreet
QNST
$1.2B
| $139M | ﹤0.01% |
7,906,837
+180,160
| +2% | +$3.24M |
|
|
ACCD
1990
DELISTED
Accolade Inc
ACCD
| $139M | ﹤0.01% |
3,290,748
+595,012
| +22% | +$28M |
|
1991
Preferred Bank
PFBC
$1.26B
| $139M | ﹤0.01% |
2,077,376
-20,325
| -1% | -$1.25M |
|
|
KREF
1992
KKR Real Estate Finance Trust
KREF
$487M
| $138M | ﹤0.01% |
6,558,204
+1,063,809
| +19% | +$22.6M |
|
1993
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
| $138M | ﹤0.01% |
1,725,311
-249,588
| -13% | -$20.7M |
|
1994
Designer Brands
DBI
$321M
| $138M | ﹤0.01% |
9,916,927
-78,757
| -0.8% | -$1.14M |
|
1995
Standard Motor Products
SMP
$889M
| $138M | ﹤0.01% |
3,156,692
-121,797
| -4% | -$5.22M |
|
1996
Verra Mobility
VRRM
$726M
| $137M | ﹤0.01% |
9,119,960
-384,520
| -4% | -$5.87M |
|
1997
Harmonic Inc
HLIT
$1.24B
| $137M | ﹤0.01% |
15,687,716
-270,792
| -2% | -$2.42M |
|
|
NBP
1998
NovaBridge Biosciences American Depositary Shares
NBP
$213M
| $137M | ﹤0.01% |
1,892,598
+100,726
| +6% | +$7.28M |
|
|
SPTN
1999
DELISTED
SpartanNash
SPTN
| $137M | ﹤0.01% |
6,258,130
+38,704
| +0.6% | +$779K |
|
2000
Atara Biotherapeutics
ATRA
$80.6M
| $137M | ﹤0.01% |
306,064
-2,737
| -0.9% | -$981K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.